Acute cardioembolic stroke: An update

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 3, 2011, Pages 367-379

  Arboix, Adrià ^a,b   Alió, Josefina ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

atrial fibrillation; cardioembolic stroke; heart failure; oral anticoagulation; patent foramen ovale; plasma biomarkers

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BRAIN NATRIURETIC PEPTIDE; DABIGATRAN; HEPARIN; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR; XIMELAGATRAN;

ARTERY OCCLUSION; BLOOD CLOT LYSIS; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORTICAL SENSORY APHASIA; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOGRAPHY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; MITRAL VALVE PROLAPSE; MORTALITY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STROKE; THORAX SURGERY; TRANSIENT ISCHEMIC ATTACK; VALSALVA MANEUVER;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; EMBOLISM; FORAMEN OVALE, PATENT; HUMANS; PROGNOSIS; RISK FACTORS; STROKE;

EID: 79953248916     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.192     Document Type: Review

References (89)

1. Ferro JM. Cardioembolic stroke: An update. Lancet Neurol. 2, 177-188 (2003). Comprehensive review on cardioembolic stroke. (Pubitemid 37443321)
2. MacDougall NJ, Amarasinghe S, Muir KW. Secondary prevention of stroke. Expert Rev. Neurother. 7(9), 1103-1115 (2009).
3. Khoo CW, Lip GY. Clinical outcomes of acute stroke patients with atrial fibrillation. Expert Rev. Cardiovasc. Ther. 7(4), 371-374 (2009). Comprehensive review on outcome in stroke patients with atrial fibrillation.
4. Arboix A, Vericat MC, Pujades R, Massons J, García-Eroles L, Oliveres M. Cardioembolic infarction in the Sagrat Cor-Alianza Hospital of Barcelona Stroke Registry. Acta Neurol. Scand. 96, 407-412 (1997). (Pubitemid 28011101)
5. Pujadas R, Arboix A, Anguera N, Rafel J, Sagués F, Casañas R. Mitral annular calcification as a marker of complex aortic atheroma in patients with stroke of uncertain etiology. Echocardiography 25, 124-131 (2008).
6. Pujadas RC, Arboix A, Casañas-Muñoz R, Anguera-Ferrando N. Specific cardiac disorders in 402 consecutive patients with ischaemic cardioembolic stroke. Int. J. Cardiol. 95, 129-134 (2004). (Pubitemid 38757617)
7. Arboix A, García-Eroles L, Massons J, Oliveres M. Predictive clinical factors of in-hospital mortality in 231 consecutive patients with cardioembolic cerebral infarction. Cerebrovasc. Dis. 8, 8-13 (1998). Clinical study of predictive factors of mortality in cardioembolic stroke. (Pubitemid 28046070)
8. Arboix A, García Eroles L, Massons JB, Oliveres M, Pujades R, Targa C. Atrial fibrillation and stroke: Clinical presentation of cardioembolic versus atherothrombotic infarction. Int. J. Cardiol. 73, 33-42 (2000). (Pubitemid 30169196)
9. Adams HP, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35-41 (1993).
10. Simons LA, Simons J, Friedlander Y, McCallum J. A comparison of risk factors for coronary heart disease and ischaemic stroke: The Dubbo Study of Australian Elderly. Heart Lung Circ. 18, 330-333 (2009).
11. Lubitz SA, Yi BA, Ellinor PT. Genetics of atrial fibrillation. Heart Fail. Clin. 6, 239-247 (2010).
12. Arboix A, García-Eroles L, Comes E et al. Importance of cardiovascular risk profile for in-hospital mortality due to cerebral infarction. Rev. Esp. Cardiol. 61, 1020-1029 (2008).
13. Ferro JM. Brain embolism. Answers to practical questions. J. Neurol. 250, 139-147 (2003). (Pubitemid 36223087)
14. Weir NU. An update on cardioembolic stroke. Postgrad. Med. J. 84, 133-142 (2008). (Pubitemid 351506209)
15. Murtagh B, Smalling RW. Cardioembolic stroke. Curr. Atherosclr. Rep. 8, 310-316 (2006). (Pubitemid 44054837)
16. Arboix A, Martí-Vilalta JL. Lacunar stroke. Expert Rev. Neurother. 9(2), 179-196 (2009).
17. Arboix A, Oliveres M, Massons J, Pujades R, García-Eroles L. Early differentiation of cardioembolic from atherothrombotic cerebral infarction: A multivariate analysis. Eur. J. Neurol. 6, 677-683 (1999).
18. Ramirez-Lassepas M, Cipolle RJ, Bjork RJ et al. Can embolic stroke be diagnosed on the basis of neurologic clinical criteria? Arch. Neurol. 44, 87-89 (1987). (Pubitemid 17087616)
19. Kittner SJ, Sharkness CM, Sloan MA et al. Infarcts with a cardiac source of embolism in the NINDS Stroke Data Bank: Neurological examination. Neurology 42, 299-302 (1992).
20. Kittner SJ, Sharkness CM, Price TR et al. Infarcts with a cardiac source of embolism in the NINSDS Stroke Data Bank: Historical features. Neurology 40, 281-284 (1990). (Pubitemid 20099440)
21. Caplan LR. Brain embolism, revisited. Neurology 43, 1281-1287 (1993). (Pubitemid 23213794)
22. Fiorelli M, Bastianello S, von Kummer R et al. Hemorrhagic transformation within 36 hours of a cerebral infarct. Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) Cohort. Stroke 30, 2280-2284 (1999). (Pubitemid 29517722)
23. Morris JG, Duffis EJ, Fisher M. Cardiac workup of ischemic stroke. Can we improve our diagnostic yield? Stroke 40, 2893-2898 (2009).
24. Marini C, De Santis F, Sacco S et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: Results from a population-based study. Stroke 36, 1115-1119 (2005). (Pubitemid 40803473)
25. Douen AG, Pageau N, Medic S. Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke. Stroke 39, 480-482 (2008). (Pubitemid 351619476)
26. Gaillard N, Deltour S, Vilotijevic B et al. Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients. Neurology 74, 1666-1670 (2010).
27. Ustrell X, Pellisé A. Cardiac workup of ischemic stroke. Current Cardiol. Rev. 6, 175-183 (2010).
28. Cacciatore A, Russo LS Jr. Lacunar infarction as an embolic complication of cardiac and arch angiography. Stroke 22, 1603-1605 (1991).
29. Lodder J, Bamford JM, Sandercock PAG, Jones LN, Warlow CP. Are hypertension or cardiac embolism likely causes of lacunar infarction? Stroke 21, 375-381 (1990). (Pubitemid 20089780)
30. Arboix A, García-Eroles K, Massons J, Oliveres M, Targa C. Lacunar infarcts in patients aged 85 years and older. Acta Neurol. Scand. 101, 25-29 (2000). (Pubitemid 30022042)
31. Di Tullio MR, Homma S. Mechanisms of cardioembolic stroke. Curr. Cardiol. Rep. 4, 141-148 (2002). Didactic and complete review on the mechanisms of cardioembolic stroke.
32. Kent DM, Trikalinos TA, Thaler DE. Patent foramen ovale and cryptogenic stroke. N. Engl. J. Med. 358, 1519-1520 (2008).
33. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 55, 1172-1179 (2000).
34. Serena J, Marti-Fàbregas J, Santamarina E et al. Recurrent stroke and massive right-to-left shunt: Results from the prospective Spanish multicenter (CODICIA) study. Stroke 39, 3131-3136 (2008). This multicenter clinical study demonstrates that essential infarctions associated with patent foramen ovale are less severe, have a lower number of recurrences and can be treated with aspirin.
35. Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 37(2), 577-617 (2006). Current guidelines of the American Academy of Neurology on secondary prevention of ischemic stroke. (Pubitemid 43732031)
36. Messé SR, Silverman IE, Kizer JR et al. Practice parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 62, 1042-1050 (2004). (Pubitemid 38456495)
37. The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee. ESO Guidelines for management of ischaemic stroke 2008. Cerebrovasc. Dis. 25, 457-507 (2008). Current guidelines of the European Stroke Organization on the management of acute stroke and secondary prevention.
38. Amarenco P, Duyckaerts C, Tzourio C, Henin D, Bousser MG, Hauw JJ. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N. Engl. J. Med. 326, 21-25 (1992).
39. Meissner I, Khandheria BK, Sheps SG et al. Atherosclerosis of the aorta: Risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiographic study. J. Am. Coll. Cardiol. 44, 1018-1024 (2004). (Pubitemid 39165136)
40. Pujadas R, Arboix A, Anguera N, Oliveres M, Massons J, Comes E. [Role of complex aortic atheroma plaques in the recurrence of unexplained cerebral infarction]. Rev. Esp. Cardiol. 58, 34-40 (2005). (Pubitemid 40372768)
41. Tunick PA, Nayar AC, Goodkin GM et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am. J. Cardiol. 90, 1333-1335 (2002).
42. Benjamin EJ, Plehn JF, D'Agostino RB et al. Mitral annular calcification and the risk of stroke in an elderly cohort. N. Engl. J. Med. 327, 374-379 (1992).
43. Hornig CR, Brainin M, Mast H. Cardioembolic stroke: Results from three current stroke data banks. Neuroepidemiology 13, 318-323 (1994). (Pubitemid 24263568)
44. Lodder J, Krijne-Kubat B, Broekman J. Cerebral hemorrhagic infarction at autopsy: Cardiac embolic cause and the relationship to the cause of death. Stroke 17, 626-629 (1986). (Pubitemid 16066529)
45. Caplan LR, Hier DB, D'Cruz I. Cerebral embolism in the Michael Reese stroke Registry. Stroke 14, 530-536 (1983). (Pubitemid 13036777)
46. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch. Neurol. 43, 71-84 (1986).
47. Arboix A, García Eroles L, Oliveres M, Massons JB, Targa C. Clinical predictors of early embolic recurrence in presumed cardioembolic infarction. Cerebrovasc. Dis. 8, 345-353 (1998). Clinical study demonstrating clinical factors associated with early embolic recurrence in cardioembolic stroke. (Pubitemid 28491096)
48. Yamanouchi H, Shimada H, Tomonaga M, Matsushita S. Recurrence of embolic stroke in non-valvular atrial fibrillation (NVAF). An autopsy study. Acta Neurol. Scand. 80, 123-129 (1989). (Pubitemid 19214654)
49. Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: The Northern Manhattan Stroke Study. Neurology 44, 626-634 (1994). (Pubitemid 24129987)
50. Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR. Determinants of early recurrence of cerebral infarction. The Stroke Data Bank. Stroke 20, 983-989 (1989). (Pubitemid 19204008)
51. Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: Analysis of 1,000 consecutive patients with first stroke. Stroke 19, 1083-1092 (1988).
52. Syme PD, Byrne AW, Chen R et al. Community-based stroke incidence in a Scottish population: The Scottish Borders Stroke Study. Stroke 36, 1837-1843 (2005). (Pubitemid 41266509)
53. The Paul Coverdell prototype Registries Writing Group. Acute stroke care in the US. Results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 36, 1232-1240 (2005).
54. Ghandehari K, Izadi Z. The Khorasan Stroke Registry: Results of five-year hospital-based study. Cerebrovasc. Dis. 23, 132-139 (2007). (Pubitemid 46239153)
55. Grau AJ, Weimar C, Buggle F et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: The German Stroke Data Bank. Stroke 32, 2559-2599 (2001).
56. Sandercock P, Bamford J, Dennis M et al. Atrial fibrillation and stroke: Prevalence in different types of stroke and influence on early and long term prognosis (Oxforsdshire community stroke project). BMJ 305, 1460-1465 (1992).
57. Bogousslavsky J, Cachin C, Regli F, Despland PA, Van Melle G, Kappenberger L. Cardiac sources of embolism and cerebral infarction - clinical consequences and vascular concomitants: The Lausanne Stroke Registry. Neurology 41, 855-859 (1991).
58. Keller TS, McGillicuddy JE, LaBond VA, Kindt GW. Volume expansion in focal cerebral ischemia: The effect of cardiac output on local cerebral blood flow. Clin. Neurosurg. 29, 40-50 (1982).
59. Lavy S, Stern S, Melamed E, Cooper G, Keren A, Levy P. Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke 11, 35-38 (1980). (Pubitemid 10160374)
60. Petersen P, Kastrup J, Videbaek R, Boysen G. Cerebral blood flow before and after cardioversion of atrial fibrillation. J. Cereb. Blood. Flow. Metab. 9, 422-425 (1989). (Pubitemid 19134820)
61. Friedman PJ. Atrial fibrillation after stroke in the elderly. Stroke 22, 209-214 (1991).
62. Censori B, Camerlingo M, Casto L, Ferraro B, Gazzaniga GC, Cesana B. Prognostic factors in first-ever stroke in the carotid territory seen within 6 hours after onset. Stroke 24, 532-535 (1993). (Pubitemid 23100737)
63. Montaner J, Perea-Gainza M, Delgado P et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 39, 2280-2287 (2008).
64. Foerch C, Montaner J, Furie KL, Ning MM, Lo EH. Searching for oracles? Blood biomarkers in acute stroke. Neurology 73, 393-399 (2009). Complete review of blood biomarkers in acute stroke.
65. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 22, 983-988 (1991).
66. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidencebased causative classification system for acute ischemic stroke. Ann. Neurol. 58, 688-697 (2005). (Pubitemid 41552544)
67. Ois A, Gomis M, Rodriguez-Campello A et al. Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke. Stroke 39, 1717-1721 (2008).
68. van de Beek D, Kremers W, Daly RC et al. Effect of neurologic complications on outcome after heart transplant. Arch. Neurol. 65, 226-231 (2008). (Pubitemid 351240785)
69. Belvís R, Martí-Fàbregas J, Cocho D et al. Cerebrovascular disease as a complication of cardiac transplantation. Cerebrovasc. Dis. 19, 267-271 (2005). (Pubitemid 40591495)
70. Fuchs S, Stabile E, Kinnaird TD et al. Stroke complicating percutaneous coronary interventions: Incidence, predictors, and prognostic implications. Circulation 106, 86-91 (2002). (Pubitemid 34752172)
71. Alió J, Esplugas E, Arboix A, Rubio F. Cerebrovascular events in cardiac catheterization. Stroke 24, 1264 (1993).
72. Wahlgren N, Ahmed N, Davalos A et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): An observational study. Lancet 369, 275-282 (2007). (Pubitemid 46138121)
73. del Zoppo GJ, Saver CJ, Jauch EC, Adams HP. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator. A science Advisory from the American Heart Association/American Stroke Association. Stroke 40, 2945-2948 (2009).
74. Gasparotti R, Grassi M, Mardighian D et al. Perfusion CT in patients with acute ischemic stroke treated with intra-arterial thrombolysis: Predictive value of infarct core size on clinical outcome. AJNR Am. J. Neuroradiol. 30, 722-727 (2009).
75. Ogawa A, Mori E, Minematsu K et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke. The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 38, 2633-2639 (2007).
76. Smith WS, Sung G, Saver J; for the Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke 39, 1205-1212 (2008). (Pubitemid 351440692)
77. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabin J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 35, 486-490 (2004). (Pubitemid 38174434)
78. Adams HP, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular radiology and intervention council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in research interdisciplinary working groups. Stroke 38, 1655-1711 (2007). Current guidelines of the American Heart Association for the management of acute ischemic stroke. (Pubitemid 46691097)
79. Doufekias E, Segal AZ, Kizer JR. Cardiogenic and aortogenic brain embolism. J. Am. Coll. Cardiol. 51, 1049-1059 (2008). (Pubitemid 351384653)
80. Cervera A, Amaro S, Obach V, Chamorro A. Prevention of ischemic stroke: Antithrombotic therapy in cardiac embolism. Curr. Drug. Targets 8, 824-831 (2007). (Pubitemid 47163392)
81. Chamorro A, Busse O, Obach V et al. The rapid anticoagulation prevents ischemic damage study in acute stroke - final results from the writing committee. Cerebrovasc. Dis. 19, 402-404 (2005). (Pubitemid 40910959)
82. Camerlingo M, Salvi P, Belloni G, Gamba T, Cesana BM, Mamoli A. Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions. Stroke 36, 2415-2420 (2005). (Pubitemid 41566969)
83. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch. Intern. Med. 154, 1449-1457 (1994).
84. No authors listed. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. JAMA 279, 1273-1277 (1998).
85. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl.), 429S-456S (2004). (Pubitemid 39302603)
86. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 119(1 Suppl.), 194S-206S (2001). (Pubitemid 32154200)
87. Gage BF, van Walraven C, Pearce L et al. Selecting patients with atrial fibrillation for anticoagulation: Stroke risk stratification in patients taking aspirin. Circulation 110, 2287-2292 (2004). (Pubitemid 39407328)
88. Wang TJ, Massaro JM, Levy D et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham Heart Study. JAMA 290, 1049-1056 (2003). (Pubitemid 37430445)
89. Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361, 1139-1151 (2009). Demonstrates the efficacy of dabigatran in the prevention of thromboembolic events in patients with atrial fibrillation.